184 related articles for article (PubMed ID: 22202154)
1. Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates.
Dahle J; Abbas N; Bruland ØS; Larsen RH
Curr Radiopharm; 2011 Oct; 4(4):321-8. PubMed ID: 22202154
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
3. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates.
Zalutsky MR; Bigner DD
Acta Oncol; 1996; 35(3):373-9. PubMed ID: 8679269
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
6. Advancements in cancer therapy with alpha-emitters: a review.
Imam SK
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):271-8. PubMed ID: 11516878
[TBL] [Abstract][Full Text] [Related]
7. An overview of targeted alpha therapy.
Kim YS; Brechbiel MW
Tumour Biol; 2012 Jun; 33(3):573-90. PubMed ID: 22143940
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
Sgouros G; Hobbs R; Josefsson A
Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
[TBL] [Abstract][Full Text] [Related]
9. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
10. Targeted alpha-therapy: past, present, future?
Brechbiel MW
Dalton Trans; 2007 Nov; (43):4918-28. PubMed ID: 17992276
[TBL] [Abstract][Full Text] [Related]
11. Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
[TBL] [Abstract][Full Text] [Related]
12. Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
Yong K; Brechbiel MW
Dalton Trans; 2011 Jun; 40(23):6068-76. PubMed ID: 21380408
[TBL] [Abstract][Full Text] [Related]
13. Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Hagemann UB; Wickstroem K; Hammer S; Bjerke RM; Zitzmann-Kolbe S; Ryan OB; Karlsson J; Scholz A; Hennekes H; Mumberg D; Cuthbertson AS
Cancer Biother Radiopharm; 2020 Sep; 35(7):497-510. PubMed ID: 32255671
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy with alpha-emitting nuclides.
McDevitt MR; Sgouros G; Finn RD; Humm JL; Jurcic JG; Larson SM; Scheinberg DA
Eur J Nucl Med; 1998 Sep; 25(9):1341-51. PubMed ID: 9724387
[TBL] [Abstract][Full Text] [Related]
15. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
[TBL] [Abstract][Full Text] [Related]
16. Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
Allen BJ
Australas Radiol; 1999 Nov; 43(4):480-6. PubMed ID: 10901964
[TBL] [Abstract][Full Text] [Related]
17. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
Lindegren S; Frost SH
Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
[TBL] [Abstract][Full Text] [Related]
18. Alpha-particles for targeted therapy.
Sgouros G
Adv Drug Deliv Rev; 2008 Sep; 60(12):1402-6. PubMed ID: 18541332
[TBL] [Abstract][Full Text] [Related]
19. Targeted Alpha Therapy with Thorium-227.
Frantellizzi V; Cosma L; Brunotti G; Pani A; Spanu A; Nuvoli S; De Cristofaro F; Civitelli L; De Vincentis G
Cancer Biother Radiopharm; 2020 Aug; 35(6):437-445. PubMed ID: 31967907
[TBL] [Abstract][Full Text] [Related]
20. Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia.
Zalutsky MR; Schuster JM; Garg PK; Archer GE; Dewhirst MW; Bigner DD
Recent Results Cancer Res; 1996; 141():101-22. PubMed ID: 8722422
[No Abstract] [Full Text] [Related]
[Next] [New Search]